Related Experiment Video
Updated: Jun 20, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Malaria and iron: history and review
1Department of Biology and Program in Medical Sciences, Indiana University, Bloomington, Indiana, USA.
Abstract:
To cause infection, nearly all protozoa, fungi, and bacteria must obtain growth-essential iron from their hosts. To suppress infection, hosts have evolved iron-withholding defense systems. Enhancement of iron withholding is a potential target for the development of novel therapeutic agents. This review focuses on the association of iron with current and emerging antimalarial drugs. Proposed mechanisms of antimalarial action of (1) iron-requiring agents, the artemisinins, are compared with (2) a spectrum of compounds that withdraw iron by chelation. A novel approach to malarial chemotherapy might involve the sequential use of a member of each of the two categories.
Insights
Malaria parasites need iron to grow. New therapies could target iron, potentially combining drugs that need iron with those that remove it to fight infection.
Area of Science:
- * Microbiology and Parasitology
- * Infectious Disease Therapeutics
- * Host-Pathogen Interactions
Background:
- * Pathogens like protozoa, fungi, and bacteria require host iron for growth and infection.
- * Host organisms possess iron-withholding defense mechanisms to combat infections.
- * Targeting these iron-withholding systems presents a promising therapeutic strategy.
Observation:
- * Iron is a critical factor in pathogen survival and host defense.
- * Existing and novel antimalarial drugs exhibit varied interactions with iron.
- * Artemisinins are iron-requiring antimalarial agents.
Findings:
- * Antimalarial drug mechanisms are explored concerning their iron dependency or iron-withdrawing properties.
- * Compounds that chelate (withdraw) iron are investigated as a class of antimalarial agents.
- * Synergistic effects may arise from combining iron-withdrawing agents with iron-requiring drugs like artemisinins.
Implications:
- * Developing novel antimalarial therapies by modulating iron availability is a viable strategy.
- * Sequential administration of iron-withdrawing compounds and artemisinins could offer a new approach to malarial chemotherapy.
- * Understanding iron's role in malaria pathogenesis can lead to innovative treatment paradigms.
Related Concept Videos
Malaria
Antiprotozoal Agents
Microbes and Other Elemental Cycles
Symbiosis
Overview of Protists
Diversity of Protists II

